Chris Mathes PhD MBA

Chief Commercial Officer
Chris Mathes, PhD, MBA is an executive with more than 25 years of experience in the biopharmaceutical industry. Mathes has expertise in pre-clinical CRO leadership, sales and marketing.

His scientific background, related to ion channel research and patch clamp technology, has brought a unique and valuable perspective to each role.

Previously, Mathes held executive leadership positions at AnaBios, Icagen, Charles River (ChanTest) and Sophion Bioscience. He earned a BS in Biology from Stanford University, received his PhD in Neuroscience from UCLA and earned an MBA from Rutgers University. His ion channel focused scientific training included post-doctoral research at Stanford University and the Max-Planck Institute for Biophysical Chemistry in Goettingen, Germany and he has published 17 peer reviewed articles. In 2018, he founded Candidate Biopharma Advisors, a consulting firm.
Metrion Biosciences

Let’s work together

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.
Contact us for a quote or discussion
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram